UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus

Vaccine, 2013-09, Vol.31 (40), p.4305-4313

2013

Volltextzugriff (PDF)

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

The New England journal of medicine, 2021-09, Vol.385 (12), p.1091-1103

2021

Volltextzugriff (PDF)

LBA13 Phase III trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)

Annals of oncology, 2023-10, Vol.34, p.S1324-S1325

2023

Volltextzugriff (PDF)

Up-and-Down Designs for Selecting the Dose with Maximum Success Probability

Sequential analysis, 2008-01, Vol.27 (1), p.78-96

2008

Volltextzugriff (PDF)

Étude de phase 3 du 177Lu-PSMA-617 dans le traitement des patients atteints d’un cancer de la prostate métastatique résistant à la castration (CPRCm) (VISION)

Médecine nucléaire : imagerie fonctionelle et métabolique, 2022-03, Vol.46 (2), p.50-51

2022

Volltextzugriff (PDF)

Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION)

Journal of clinical oncology, 2021-06, Vol.39 (18_suppl), p.LBA4-LBA4

2021

Volltextzugriff (PDF)

Nucleoside Exposure in the Children of HIV-Infected Women Receiving Antiretroviral Drugs: Absence of Clear Evidence for Mitochondrial Disease in Children Who Died Before 5 Years of Age in Five United States Cohorts

Journal of acquired immune deficiency syndromes (1999), 2000-11, Vol.25 (3), p.261-268

2000

Volltextzugriff (PDF)

A one-sample progression-free survival (PFS) hazard ratio estimate for planning a randomized phase II study (RP2) in mRCC utilizing evidence from RECORD-1

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e16515-e16515

2010

Volltextzugriff (PDF)

Phase III, randomized, placebo-controlled study of everolimus in patients with metastatic renal cell carcinoma (mRCC): Subgroup analysis of patients intolerant of prior vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy

Journal of clinical oncology, 2011-03, Vol.29 (7_suppl), p.312-312

2011

Volltextzugriff (PDF)

Everolimus in metastatic renal cell carcinoma (mRCC): Subgroup analysis of patients (pts) with one versus two prior vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) therapies enrolled in the phase III RECORD-1 study

Journal of clinical oncology, 2011-03, Vol.29 (7_suppl), p.304-304

2011

Volltextzugriff (PDF)

Mode of Delivery and Postpartum Morbidity Among HIV-Infected Women: The Women and Infants Transmission Study

Journal of acquired immune deficiency syndromes (1999), 2001-03, Vol.26 (3), p.236-245

2001

Volltextzugriff (PDF)

Transfused Myelodysplastic Syndromes (MDS) Patients Have Severe Iron Overload and Relevant Improvements in Iron Burden and Liver Function with Deferasirox Treatment: Results From a Pooled Analysis

Blood, 2011-11, Vol.118 (21), p.5019-5019

2011

Volltextzugriff (PDF)

719 EVEROLIMUS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: SUBGROUP ANALYSIS OF PATIENTS WITH A REDUCTION IN TUMOR BURDEN ENROLLED IN A RANDOMIZED, PLACEBO-CONTROLLED, PHASE II TRIAL

European urology supplements : official journal of the European Association of Urology, 2011, Vol.10 (2), p.229-229

2011

Volltextzugriff (PDF)

Drug Safety during Pregnancy and in Infants: Lack of Mortality Related to Mitochondrial Dysfunction among Perinatally HIV-Exposed Children in Pediatric HIV Surveillance

Annals of the New York Academy of Sciences, 2000-11, Vol.918 (1), p.222-235

2000

Volltextzugriff (PDF)

Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study

Journal of acquired immune deficiency syndromes (1999), 2001-03, Vol.26 (3), p.236-245

2001

Volltextzugriff (PDF)

AN OPTIMIZING UP-AND-DOWN DESIGN

Optimum Design 2000, 2001, Vol.51, p.211-224

2001

Volltextzugriff (PDF)

Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry

Journal of immunological methods, 2015-02, Vol.417, p.22-33

2015

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(16)
Buchkapitel
(1)

Sprache

Englisch
(16)
Französisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

LBA13 Phase III trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)

Up-and-Down Designs for Selecting the Dose with Maximum Success Probability

Étude de phase 3 du 177Lu-PSMA-617 dans le traitement des patients atteints d’un cancer de la prostate métastatique résistant à la castration (CPRCm) (VISION)

Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION)

Nucleoside Exposure in the Children of HIV-Infected Women Receiving Antiretroviral Drugs: Absence of Clear Evidence for Mitochondrial Disease in Children Who Died Before 5 Years of Age in Five United States Cohorts

A one-sample progression-free survival (PFS) hazard ratio estimate for planning a randomized phase II study (RP2) in mRCC utilizing evidence from RECORD-1

Phase III, randomized, placebo-controlled study of everolimus in patients with metastatic renal cell carcinoma (mRCC): Subgroup analysis of patients intolerant of prior vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy

Everolimus in metastatic renal cell carcinoma (mRCC): Subgroup analysis of patients (pts) with one versus two prior vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) therapies enrolled in the phase III RECORD-1 study

Mode of Delivery and Postpartum Morbidity Among HIV-Infected Women: The Women and Infants Transmission Study

Transfused Myelodysplastic Syndromes (MDS) Patients Have Severe Iron Overload and Relevant Improvements in Iron Burden and Liver Function with Deferasirox Treatment: Results From a Pooled Analysis

719 EVEROLIMUS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: SUBGROUP ANALYSIS OF PATIENTS WITH A REDUCTION IN TUMOR BURDEN ENROLLED IN A RANDOMIZED, PLACEBO-CONTROLLED, PHASE II TRIAL

Drug Safety during Pregnancy and in Infants: Lack of Mortality Related to Mitochondrial Dysfunction among Perinatally HIV-Exposed Children in Pediatric HIV Surveillance

Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study

AN OPTIMIZING UP-AND-DOWN DESIGN

Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry

Suchergebnisse filtern